Who
Steven P. Coen
Officer
Company insider
Files Form 4 as: Officer, Ginkgo Bioworks Holdings.
In numbers
- Trades disclosed
- 175
- Buys
- 0
- Sells
- 27
- Bought
- $0
- Sold
- $807K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Jul 2023
- Last trade
- 19 Oct 2026
- Last filed
- 21 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Oct 2026filed 21 Oct 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Sold | $7,770766 at $10.14 | filing |
| 16 Oct 2026filed 21 Oct 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —1,174 | filing |
| 16 Oct 2026filed 21 Oct 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —312 | filing |
| 16 Oct 2026filed 21 Oct 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,174 | filing |
| 16 Oct 2026filed 21 Oct 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —312 | filing |
| 5 Oct 2026filed 7 Oct 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Sold | $36K2,403 at $15.00 | filing |
| 24 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Sold | $2,302330 at $6.98 | filing |
| 24 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Sold | $2,303330 at $6.98 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —587 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —156 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —587 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —156 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —587 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —156 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —587 | filing |
| 21 Aug 2026filed 25 Aug 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —156 | filing |
| 17 Jul 2026filed 20 Jul 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Sold | $5,943752 at $7.90 | filing |
| 17 Jul 2026filed 20 Jul 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Sold | $5,941752 at $7.90 | filing |
| 16 Jul 2026filed 20 Jul 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —1,174 | filing |
| 16 Jul 2026filed 20 Jul 2026 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —312 | filing |
News
Reviewing Bullfrog AI (NASDAQ:BFRG) & Ginkgo Bioworks (NYSE:DNA)DNA · themarketsdaily.com · 24 Oct 2026Insider Selling: Ginkgo Bioworks (NYSE:DNA) Insider Sells 45,682 Shares of Company StockDNA · tickerreport.com · 21 Oct 2026Ginkgo Bioworks (NYSE:DNA) Major Shareholder Barry Canton Sells 22,369 Shares of Company StockDNA · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Steven P. Coen; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.